Italia markets closed

BMY Jul 2024 40.000 call

OPR - OPR Prezzo differito. Valuta in USD.
Aggiungi a watchlist
0,1200-0,4300 (-78,18%)
In data: 12:59PM EDT. Mercato aperto.
Schermo intero
Chiusura precedente0,5500
Aperto0,3500
Denaro0,1000
Domanda0,2000
Prezzo d'esercizio40,00
Scadenza2024-07-05
Min-Max giorno0,1200 - 0,3500
Contratto - Min-MaxN/D
Volume693
Open Interest180
  • GlobeNewswire

    Arbutus Appoints Two New Executives

    Karen Sims, MD, PhD Promoted to Chief Medical Officer Christopher Naftzger Appointed as General Counsel and Chief Compliance Officer WARMINSTER, Pa., July 10, 2023 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS) (“Arbutus” or the “Company”), a clinical-stage biopharmaceutical company leveraging its extensive virology expertise to develop novel therapeutics that target specific viral diseases, today announced the appointment of Dr. Karen Sims as Chief Medical Officer and Mr. Chri